Form4insider filings, from the source

Company · CIK 0001674632 · SIC 3841 — Surgical & Medical Instruments & Apparatus · Nasdaq

Beta Bionics, Inc. · BBNX

Insider activity reported against this company. All insider holders · On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $3.1M · 21net −$3.1M
$10k$10k$100k$100k$1M$1MbuyssalesJun 1Jun 20Jul 9Jul 28Aug 16Sep 4Sep 23

Reported at this company — common stock

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Sep 22, 2026 SForm 4 →Sep 23, 5:40 pm EDTChristy JonesDirector6,430$23.00$147,89019,564−24.7%10b5-1
Sep 16, 2026 SForm 4 →Sep 17, 4:15 pm EDTMark HopmanChief Commercial Officer30,779$20.13$619,64056,479−35.3%10b5-1
Sep 16, 2026 SForm 4 →Sep 17, 4:15 pm EDTMike MensingerChief Product Officer2,650$22.00$58,300177,390−1.47%10b5-1
Sep 14, 2026 SForm 4 →Sep 15, 4:15 pm EDTMark HopmanChief Commercial Officer775$15.52$12,02886,382−0.89%10b5-1
Sep 9, 2026 SForm 4/A →Sep 18, 7:51 pm EDTMark HopmanChief Commercial Officer35,994$18.46$664,55088,033−29.0%10b5-1
Sep 9, 2026 SForm 4 →Sep 10, 4:30 pm EDTMark HopmanChief Commercial Officer36,870$18.46$680,72387,157−29.7%10b5-1 amended
Sep 3, 2026 SForm 4 →Sep 4, 5:19 pm EDTSean SaintPresident & CEO, Director5,641$20.08$113,259398,429−1.40%10b5-1
Sep 2, 2026 SForm 4 →Sep 3, 6:15 pm EDTMark HopmanChief Commercial Officer5,327$19.11$101,815124,027−4.12%
Sep 2, 2026 SForm 4 →Sep 3, 6:15 pm EDTSteven Jon RussellChief Medical Officer4,221$19.11$80,676169,628−2.43%
Sep 2, 2026 SForm 4 →Sep 3, 6:15 pm EDTMike MensingerChief Product Officer4,375$19.11$83,620180,040−2.37%
Sep 2, 2026 SForm 4 →Sep 3, 6:15 pm EDTStephen FeiderChief Financial Officer6,675$19.11$127,580159,378−4.02%
Sep 2, 2026 SForm 4 →Sep 3, 6:15 pm EDTSean SaintPresident & CEO, Director16,867$19.11$322,381404,070−4.01%
Jun 26, 2026 SForm 4/A →Jul 2, 6:44 pm EDTStephen FeiderChief Financial Officer10,000$17.04$170,387166,053−5.68%10b5-1
Jun 26, 2026 MForm 4/A →Jul 2, 6:44 pm EDTStephen FeiderChief Financial Officer10,000$5.10$51,000170,949—10b5-1
Jun 26, 2026 SForm 4 →Jun 30, 4:46 pm EDTStephen FeiderChief Financial Officer10,000$17.04$170,387165,931−5.68%10b5-1 amended
Jun 26, 2026 MForm 4 →Jun 30, 4:46 pm EDTStephen FeiderChief Financial Officer9,878$5.10$50,378170,827—10b5-1 amended
Jun 24, 2026 SForm 4 →Jun 25, 4:34 pm EDTMark HopmanChief Commercial Officer1,258$15.01$18,880129,354−0.96%10b5-1
Jun 24, 2026 SForm 4 →Jun 25, 4:32 pm EDTChristy JonesDirector1,406$15.00$21,09025,994−5.13%10b5-1
Jun 4, 2026 SForm 4 →Jun 5, 6:05 pm EDTMark HopmanChief Commercial Officer275$12.31$3,385130,612−0.21%10b5-1
Jun 4, 2026 SForm 4 →Jun 5, 6:05 pm EDTChristy JonesDirector2,811$14.00$39,35427,400−9.30%10b5-1
Jun 2, 2026 SForm 4 →Jun 3, 6:13 pm EDTMike MensingerChief Product Officer4,378$12.61$55,194184,415−2.32%
Jun 2, 2026 SForm 4 →Jun 3, 6:00 pm EDTMark HopmanChief Commercial Officer5,329$12.61$67,183130,887−3.91%
Jun 2, 2026 SForm 4 →Jun 3, 6:00 pm EDTSteven Jon RussellChief Medical Officer4,222$12.61$53,227173,849−2.37%
Jun 2, 2026 SForm 4 →Jun 3, 6:00 pm EDTStephen FeiderChief Financial Officer6,676$12.61$84,165166,053−3.87%
Jun 2, 2026 SForm 4 →Jun 3, 6:00 pm EDTSean SaintPresident & CEO, Director16,872$12.61$212,707420,937−3.85%

Reported at this company — derivatives (options, RSUs, warrants)

TradeReported (ET)InsiderSharesAvg priceTotalOwned afterΔ stakeFlags
Jun 26, 2026 MForm 4/A →Jul 2, 6:44 pm EDTStephen FeiderChief Financial Officer10,000——39,695—10b5-1
Jun 26, 2026 MForm 4 →Jun 30, 4:46 pm EDTStephen FeiderChief Financial Officer9,878——39,817—10b5-1 amended